Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-FISETIN
NCT04476953Phase 2Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Aug 2020
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in coronavirus disease 2019 (COVID-19), sponsored by Mayo Clinic. Started Aug 2020; status: active, not recruiting.
02
Drugs
fisetin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04476953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476953.